Alemtuzumab 12 mg vial
This tender has been awarded
Awarded to Sanofi Aventis, SA; Merck,SL; Roche Farma, SA; JUVISE PHARMACEUTICALS; Neuraxpharm spain,SLU — €6,163
About This Opportunity
Supplies contract awarded by Dirección General de Gestión Económica (Spain): Alemtuzumab 12 mg vial. healthcare. Awarded to Sanofi Aventis, SA; Merck,SL (EUR.
This is a supplies contract in the health and medical services sector. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 388,238.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Alemtuzumab 12 mg vial
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on May 3, 2026. Last refreshed 140 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad has issued 167 procurement notices on BidsFactory, including 7 currently open and 72 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and Information & Communication Technology. All notices are published for Spain. Notices are distributed via PLACSP - Plataforma de Contratación del Sector Público and TED - Tenders Electronic Daily (EU). Most recent publication: October 1, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Sanofi Aventis, SA; Merck,SL; Roche Farma, SA; JUVISE PHARMACEUTICALS; Neuraxpharm spain,SLU. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Sanofi Aventis, SA; Merck,SL; Roche Farma, SA; JUVISE PHARMACEUTICALS; Neuraxpharm spain,SLU was awarded the contract for €6,163. The figure reflects the value disclosed by the contracting authority in the award notice.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.